These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 8374000)

  • 1. Effects of human salivas on recombinant HIV-1 proteins.
    Archibald DW; Hebert CA; Gregory KL; Lewis GK
    Crit Rev Oral Biol Med; 1993; 4(3-4):475-8. PubMed ID: 8374000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV antibody EIA and western blot assay results on paired serum and saliva specimens.
    Fitzgibbons D; Barriga G; Seymour E; Stramer S
    Ann N Y Acad Sci; 1993 Sep; 694():314-6. PubMed ID: 8215076
    [No Abstract]   [Full Text] [Related]  

  • 3. Variation of secretory antibodies in parotid saliva to human immunodeficiency virus type 1 with HIV-1 disease stage.
    Sun D; Archibald DW; Furth PA
    AIDS Res Hum Retroviruses; 1990 Jul; 6(7):933-41. PubMed ID: 2117957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the secreted, native gp120 and gp160 of the human immunodeficiency virus type 1.
    Kalyanaraman VS; Rodriguez V; Veronese F; Rahman R; Lusso P; DeVico AL; Copeland T; Oroszlan S; Gallo RC; Sarngadharan MG
    AIDS Res Hum Retroviruses; 1990 Mar; 6(3):371-80. PubMed ID: 2187500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1.
    Gu M; Rappaport J; Leppla SH
    FEBS Lett; 1995 May; 365(1):95-7. PubMed ID: 7774724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometric assays for monitoring production of recombinant HIV-1 gp160 in insect cells infected with a baculovirus expression vector.
    Farmer JL; Hampton RG; Boots E
    J Virol Methods; 1989 Dec; 26(3):279-90. PubMed ID: 2695538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of HIV-1 envelope glycoproteins gp120 and gp160 on the in vitro growth of enriched (CD34+) hematopoietic progenitor cells.
    Zauli G; Re MC; Visani G; Furlini G; La Placa M
    Arch Virol; 1992; 122(3-4):271-80. PubMed ID: 1370604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improbability of harmful autoimmune responses resulting from immunization with HIV-1 envelope glycoproteins.
    Neurath AR; Strick N; Li YY; Jiang S
    AIDS Res Hum Retroviruses; 1993 Dec; 9(12):1195-208. PubMed ID: 8142138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calcium requirement and inhibitor spectrum for intracellular HIV type 1 gp160 processing in cultured HeLa cells and CD4+ lymphocytes: similarity to those of viral envelope glycoprotein maturase.
    Kamoshita K; Shiota M; Sasaki M; Koga Y; Okumura Y; Kido H
    J Biochem; 1995 Jun; 117(6):1244-53. PubMed ID: 7490267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adhesion mediated by intercellular adhesion molecule 1 attenuates the potency of antibodies that block HIV-1 gp160-dependent syncytium formation.
    Berman PW; Nakamura GR
    AIDS Res Hum Retroviruses; 1994 May; 10(5):585-93. PubMed ID: 7917519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunogenicity and epitope mapping of a recombinant soluble gp160 of the human immunodeficiency virus type 1 envelope glycoprotein.
    Pasquali JL; Kieny MP; Kolbe H; Christmann D; Knapp AM
    AIDS Res Hum Retroviruses; 1990 Sep; 6(9):1107-13. PubMed ID: 1702300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface plasmon resonance for detection and measurement of antibody-antigen affinity and kinetics.
    Malmqvist M
    Curr Opin Immunol; 1993 Apr; 5(2):282-6. PubMed ID: 8507407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro inhibition of HIV-1 infectivity by human salivas.
    Archibald DW; Cole GA
    AIDS Res Hum Retroviruses; 1990 Dec; 6(12):1425-32. PubMed ID: 2078420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human glandular salivas: their separate collection and analysis.
    Veerman EC; van den Keybus PA; Vissink A; Nieuw Amerongen AV
    Eur J Oral Sci; 1996 Aug; 104(4 ( Pt 1)):346-52. PubMed ID: 8930581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mapping of HIV-1 gp160 epitopes required for interleukin-1 and tumor necrosis factor alpha production in glial cells.
    Koka P; He K; Camerini D; Tran T; Yashar SS; Merrill JE
    J Neuroimmunol; 1995 Mar; 57(1-2):179-91. PubMed ID: 7706435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kex2p: a model for cellular endoprotease processing human immunodeficiency virus type 1 envelope glycoprotein precursor.
    Moulard M; Achstetter T; Kieny MP; Montagnier L; Bahraoui E
    Eur J Biochem; 1994 Oct; 225(2):565-72. PubMed ID: 7957171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of the envelope glycoprotein of human immunodeficiency virus with C1q and fibronectin under conditions present in human saliva.
    Su H; Boackle RJ
    Mol Immunol; 1991 Aug; 28(8):811-7. PubMed ID: 1875953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced proteolytic processing of the human immunodeficiency virus type 1 envelope protein in murine Ltk(-) cells.
    Rodriguez D; Rodriguez JR; Esteban M
    AIDS Res Hum Retroviruses; 1995 Jan; 11(1):81-5. PubMed ID: 7734199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of endoproteolytic cleavage and intracellular transport of human immunodeficiency virus type 1 envelope glycoproteins using mutant CD4 molecules bearing the transmembrane endoplasmic reticulum retention signal.
    Raja NU; Vincent MJ; Jabbar MA
    J Gen Virol; 1993 Oct; 74 ( Pt 10)():2085-97. PubMed ID: 8409933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folding, assembly, and intracellular trafficking of the human immunodeficiency virus type 1 envelope glycoprotein analyzed with monoclonal antibodies recognizing maturational intermediates.
    Otteken A; Earl PL; Moss B
    J Virol; 1996 Jun; 70(6):3407-15. PubMed ID: 8648672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.